Related Experiment Video
Updated: Jan 24, 2026

Modeling Spontaneous Metastatic Renal Cell Carcinoma mRCC in Mice Following Nephrectomy
Published on: April 29, 2014
Epigenetic dysregulation by aberrant metabolism in renal cell carcinoma can be reversed with Ascorbic acid
1Department of Medicine (Oncology), Albert Einstein College of Medicine, Montefiore Medical Center, New York, USA.
Abstract:
Our recently published study uncovered mechanisms and prognostic impact of aberrant DNA methylation/hydroxymethylation in clear cell renal cell carcinoma, and comprehensively explored the potential of Ascorbic acid in reversing the epigenetic aberrancy. This article provides a summary of the findings and their translational significance, and important considerations while testing Ascorbic acid as an anti-cancer agent. Abbreviations- ccRCC: clear cell renal cell carcinoma; TET: Ten-Eleven Translocation; 5mC: 5-methylcytosine; 5hmC: 5-hydroxymethylcytosine; L2HG: l-2-hydroxyglutarate; L2HGDH: l-2-hydroxyglutarate dehydrogenase; 2-OG: 2-Oxoglutarate; AA: Ascorbic acid.
Insights
Aberrant DNA methylation and hydroxymethylation impact clear cell renal cell carcinoma (ccRCC) prognosis. Ascorbic acid shows potential in reversing these epigenetic changes, offering a novel anti-cancer strategy.
Area of Science:
- Epigenetics
- Oncology
- Biochemistry
Background:
- Clear cell renal cell carcinoma (ccRCC) exhibits aberrant DNA methylation and hydroxymethylation patterns.
- These epigenetic alterations are linked to patient prognosis and tumor progression.
- The Ten-Eleven Translocation (TET) family of enzymes plays a crucial role in DNA demethylation and hydroxymethylation.
Purpose of the Study:
- To elucidate the mechanisms and prognostic significance of DNA methylation/hydroxymethylation in ccRCC.
- To investigate the potential of Ascorbic acid (AA) in reversing epigenetic aberrancies in ccRCC.
- To summarize findings and discuss considerations for testing AA as an anti-cancer agent.
Main Methods:
- Analysis of DNA methylation (5-methylcytosine, 5mC) and hydroxymethylation (5-hydroxymethylcytosine, 5hmC) patterns in ccRCC.
- Assessment of the prognostic impact of these epigenetic marks.
- In vitro and/or in vivo studies exploring the effects of Ascorbic acid on epigenetic modifications and ccRCC progression.
Main Results:
- Identified specific DNA methylation/hydroxymethylation signatures associated with ccRCC.
- Demonstrated a significant correlation between these epigenetic patterns and patient outcomes.
- Showcased Ascorbic acid's ability to reverse specific epigenetic aberrancies, potentially impacting ccRCC growth.
Conclusions:
- Aberrant DNA methylation/hydroxymethylation are key drivers and prognostic markers in ccRCC.
- Ascorbic acid emerges as a promising therapeutic agent for reversing epigenetic dysregulation in ccRCC.
- Further clinical investigation of Ascorbic acid for ccRCC treatment is warranted.
More Related Videos
05:36Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane
Published on: February 8, 2020
06:38A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
Published on: April 12, 2017
Related Concept Videos
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
What is Metabolism?
Overview of Fatty Acid Metabolism
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
Renal Regulation of Acid-Base Balance
In the kidneys, cells within the proximal convoluted tubules (PCT) and the collecting ducts secrete hydrogen ions (H+) into the tubular fluid. Specifically, in the PCT, Na+/H+ antiporters secrete H+ while reabsorbing Na+.
However, the intercalated cells in...
Polyprotic Acids